[Tumor markers. Current use in antineoplastic strategy].
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000941:Antigens / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D002116:Calcitonin / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000097:blood; D004796:Clinical Enzyme Tests; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005353:Fibronectins / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D010281:Parathyroid Hormone / Q000097:blood; D010455:Peptides / Q000032:analysis; D010960:Plasminogen Activators / Q000032:analysis; D019396:Tissue Polypeptide Antigen; D014667:Vasopressins / Q000097:blood; D000509:alpha-Fetoproteins / Q000032:analysis
D000941:Antigens; D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D005338:Fibrin Fibrinogen Degradation Products; D005353:Fibronectins; D006023:Glycoproteins; D010281:Parathyroid Hormone; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; C024533:fetal sulfoglycoprotein antigen, human; C031192:oncofetal antigens; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D002116:Calcitonin; D010960:Plasminogen Activators
Markers tumorali. Attuale utilizzazione nella strategia antineoplastica.